Table 5 Long-term hematopoietic reconstitution.

From: Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation

180 days after ASCT

rhTPO group (n=24)

Control group (n=12)

p value

ANC, ×109/L (range)

3.003 (1.554–4.984)

3.241 (2.058–3.976)

0.405

Hemoglobin level, g/L (range)

122 (65–155)

129.3 (94–149)

0.306

PLTc, ×109/L (range)

134 (64–233)

158.9 (36–216)

0.174

Neutropenia, n (%)

  

0.671

 Grade I

6 (25%)

2 (16.7%)

 

 Grade II

4 (16.7%)

1 (8.3%)

 

 Grade III

0

0

 

 Grade IV

0

0

 

Anemia, n (%)

  

1.000

 Grade I

1 (4.2%)

1 (8.3%)

 

 Grade II

2 (8.3%)

0

 

 Grade III

0

0

 

 Grade IV

0

0

 

Thrombocytopenia, n (%)

  

0.126

 Grade I

4 (16.7%)

0

 

 Grade II

3 (12.5%)

0

 

 Grade III

0

1 (8.3%)

 

 Grade IV

0

0

 
  1. ASCT autologous stem cell transplantation, rhTPO recombinant human thrombopoietin, ANC absolute neutrophil count, PLTc platelet count.